S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
NASDAQ:ENTA

Enanta Pharmaceuticals SEC Filings & 10K Form

$41.87
-2.14 (-4.86%)
(As of 05/20/2022 04:00 PM ET)
Add
Compare
Today's Range
$39.36
$44.52
50-Day Range
$41.87
$76.93
52-Week Range
$38.02
$102.00
Volume
500,937 shs
Average Volume
286,943 shs
Market Capitalization
$867.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.64

Enanta Pharmaceuticals (NASDAQ:ENTA) SEC Filings

DateFilerForm TypeView
05/17/2022
3:37 PM
Enanta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2022
3:07 PM
Enanta Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/23/2021
3:38 PM
Enanta Pharmaceuticals (Issuer)
Hata Yujiro S (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/23/2021
3:01 PM
Enanta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2021
5:45 PM
Enanta Pharmaceuticals (Issuer)
Vance Terry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2021
5:37 PM
Enanta Pharmaceuticals (Issuer)
Russell Lesley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2021
5:29 PM
Enanta Pharmaceuticals (Issuer)
Peterson Kristine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2021
5:24 PM
Enanta Pharmaceuticals (Issuer)
FOLETTA MARK G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2021
5:17 PM
CARTER BRUCE L A (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
4:05 PM
ARMISTICE CAPITAL, LLC (Filed by)
Enanta Pharmaceuticals (Subject)
Form SC 13G
02/10/2021
11:19 AM
Enanta Pharmaceuticals (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
Form SC 13G
02/09/2021
11:33 AM
Enanta Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
02/08/2021
3:05 PM
Enanta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2021
4:41 PM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2021
7:40 AM
Dworsky Alan J (Filed by)
Enanta Pharmaceuticals (Subject)
Form SC 13G/A
01/27/2021
4:47 PM
Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2021
4:33 PM
Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/21/2021
3:25 PM
Enanta Pharmaceuticals (Filer)
Form DEF 14A
01/08/2021
7:57 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2020
5:51 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2020
5:43 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2020
5:35 PM
Adda Nathalie (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2020
5:27 PM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2020
5:20 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2020
6:16 PM
Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2020
6:07 PM
Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/07/2020
4:38 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2020
3:00 PM
Enanta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/25/2020
3:01 PM
Enanta Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
11/20/2020
7:36 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2020
7:34 PM
Adda Nathalie (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2020
7:30 PM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2020
7:25 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2020
7:21 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2020
3:06 PM
Enanta Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/04/2020
3:16 PM
Enanta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2020
6:19 PM
Enanta Pharmaceuticals (Issuer)
FOLETTA MARK G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2020
6:08 PM
Enanta Pharmaceuticals (Issuer)
FOLETTA MARK G (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/30/2020
3:00 PM
Enanta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2020
3:08 PM
Enanta Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2020
4:35 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2020
5:27 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
3:05 PM
Enanta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2020
4:24 PM
Enanta Pharmaceuticals (Issuer)
Vance Terry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2020
4:18 PM
Enanta Pharmaceuticals (Issuer)
Russell Lesley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
5:07 AM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
5:06 AM
Adda Nathalie (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
5:05 AM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
5:04 AM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
5:03 AM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
5:19 AM
Enanta Pharmaceuticals (Subject)
FARALLON CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G/A
02/13/2020
9:33 AM
Enanta Pharmaceuticals (Subject)
SHIONOGI & CO LTD (Filed by)
SHIONOGI & CO LTD (Filed by)
Form SC 13G/A
02/04/2020
10:53 AM
BlackRock Inc. (Filed by)
Enanta Pharmaceuticals (Subject)
Form SC 13G/A
01/23/2020
11:35 AM
Dworsky Alan J (Filed by)
Enanta Pharmaceuticals (Subject)
Form SC 13G/A
01/06/2020
5:21 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
5:20 PM
Adda Nathalie (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
5:19 PM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
5:18 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
5:17 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2019
3:06 PM
Enanta Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
11/21/2019
3:05 PM
Enanta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2019
5:48 PM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2019
5:47 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2019
5:45 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2019
5:44 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2019
5:44 PM
Adda Nathalie (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2019
4:17 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2019
3:45 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2019
3:25 PM
Enanta Pharmaceuticals (Subject)
FARALLON CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G
08/09/2019
3:06 PM
Enanta Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2019
3:06 PM
Enanta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2019
5:33 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
3:32 PM
Enanta Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/10/2019
3:13 PM
Enanta Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/10/2019
3:01 PM
Enanta Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2019
3:04 PM
Enanta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2019
3:51 PM
CARTER BRUCE L A (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2019
3:20 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2019
3:15 PM
Enanta Pharmaceuticals (Filer)
Form 8-K/A
03/06/2019
4:00 PM
Enanta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2019
3:51 PM
Enanta Pharmaceuticals (Issuer)
Golumbeski George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
5:14 PM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
7:08 PM
Enanta Pharmaceuticals (Issuer)
Vance Terry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
7:06 PM
Enanta Pharmaceuticals (Issuer)
Russell Lesley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
7:05 PM
Enanta Pharmaceuticals (Issuer)
Peterson Kristine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
7:04 PM
Enanta Pharmaceuticals (Issuer)
Golumbeski George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
7:03 PM
CARTER BRUCE L A (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
7:03 PM
Buckley Stephen Jr. (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
12:50 PM
Enanta Pharmaceuticals (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G
02/13/2019
8:40 PM
Enanta Pharmaceuticals (Issuer)
Ocain Tim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2019
8:33 PM
Adda Nathalie (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2019
8:28 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2019
8:21 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2019
8:16 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2019
8:11 PM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2019
7:57 PM
Enanta Pharmaceuticals (Issuer)
Golumbeski George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2019
7:50 PM
CARTER BRUCE L A (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2019
1:11 PM
Enanta Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
02/11/2019
9:31 AM
Enanta Pharmaceuticals (Subject)
FIRST MANHATTAN CO (Filed by)
Form SC 13G/A
02/08/2019
8:40 AM
Dworsky Alan J (Filed by)
Enanta Pharmaceuticals (Subject)
Form SC 13G/A
This page was last updated on 5/22/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.